<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Free radical-mediated neuronal cell damage is an important <z:mpath ids='MPATH_596'>pathological process</z:mpath> in <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We have previously reported a novel dual-functional agent, 2-[[(<z:chebi fb="0" ids="30355">1,1-dimethylethyl</z:chebi>)oxidoimino]-<z:chebi fb="36" ids="29309">methyl</z:chebi>]-3,5,6-trimethylpyrazine (TBN), a derivative of tetramethylpyrazine armed with anitrone moiety </plain></SENT>
<SENT sid="2" pm="."><plain>In this report, we further evaluate TBN'stherapeutic parameters in a rat middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) model </plain></SENT>
<SENT sid="3" pm="."><plain>Its abilities to cross the blood-brain barrier, scavenge free radicals, and inhibit Ca(2+) influx were also investigated </plain></SENT>
<SENT sid="4" pm="."><plain>TBN showed significant activity in both the transient MCAO (t-MCAO) and permanent MCAO (p-MCAO) <z:hpo ids='HP_0001297'>stroke</z:hpo> models in the rat </plain></SENT>
<SENT sid="5" pm="."><plain>The therapeutic time window is 8 hr in the t-MCAO model </plain></SENT>
<SENT sid="6" pm="."><plain>TBN readily crossed the blood-brain barrier and in vitro had strong activity in neutralizing 路OH, O(-)(2)路, and <z:chebi fb="0" ids="29330">ONOO</z:chebi>(-) and significantly decreased intracellular Ca(2+) concentration </plain></SENT>
<SENT sid="7" pm="."><plain>TBN is a promising new treatment forischemic <z:hpo ids='HP_0001297'>stroke</z:hpo>, with multiple mechanisms of action </plain></SENT>
<SENT sid="8" pm="."><plain>It blocks Ca(2+) overload and neutralizes 路OH, O(-)(2)路, and <z:chebi fb="0" ids="29330">ONOO</z:chebi>(-) </plain></SENT>
</text></document>